Mike Pishvaian
@mpishvaian.bsky.social
GI Oncologist at Johns Hopkins, focusing on #PancreaticCancer and #PrecisionMedicine. Striving to improve patient outcomes.
Originator of #TumorBoardTuesday
@tumorboardtuesday.bsky.social @TumorBoardTues
Originator of #TumorBoardTuesday
@tumorboardtuesday.bsky.social @TumorBoardTues
@hopkinspress.bsky.social
#GIOnc
🌇And in our last discussion of the day, @EileenMOReilly shared with us her experience with, and promise of the many ongoing trials of novel KRAS⛔️
🙏There is real promise here that KRAS⛔️will improve the mOS of #pancreaticcancer patients across the board🙏
#GIOnc
🌇And in our last discussion of the day, @EileenMOReilly shared with us her experience with, and promise of the many ongoing trials of novel KRAS⛔️
🙏There is real promise here that KRAS⛔️will improve the mOS of #pancreaticcancer patients across the board🙏
February 8, 2025 at 8:45 PM
@hopkinspress.bsky.social
#GIOnc
🌇And in our last discussion of the day, @EileenMOReilly shared with us her experience with, and promise of the many ongoing trials of novel KRAS⛔️
🙏There is real promise here that KRAS⛔️will improve the mOS of #pancreaticcancer patients across the board🙏
#GIOnc
🌇And in our last discussion of the day, @EileenMOReilly shared with us her experience with, and promise of the many ongoing trials of novel KRAS⛔️
🙏There is real promise here that KRAS⛔️will improve the mOS of #pancreaticcancer patients across the board🙏
@hopkinspress.bsky.social
#GIOnc
➡️Pancreatic enzyme insufficiency is very challening for patients with #pancreaticcancer (and difficult for their physicians to manage)
✅We need dieticians like Mary-Eve Brown to help us manage these patients
#GIOnc
➡️Pancreatic enzyme insufficiency is very challening for patients with #pancreaticcancer (and difficult for their physicians to manage)
✅We need dieticians like Mary-Eve Brown to help us manage these patients
February 8, 2025 at 8:33 PM
@hopkinspress.bsky.social
#GIOnc
➡️Pancreatic enzyme insufficiency is very challening for patients with #pancreaticcancer (and difficult for their physicians to manage)
✅We need dieticians like Mary-Eve Brown to help us manage these patients
#GIOnc
➡️Pancreatic enzyme insufficiency is very challening for patients with #pancreaticcancer (and difficult for their physicians to manage)
✅We need dieticians like Mary-Eve Brown to help us manage these patients
@hopkinspress.bsky.social
#GIOnc
✅@NeehaZaidi presented a slightly different view that we need studies to understand which patients with oligometastatic #pancreaticcancer would benefit from surgery
🤔Should we be considering adjunctive Tx, such as vaccines, that might⬆️long-term control❓
#GIOnc
✅@NeehaZaidi presented a slightly different view that we need studies to understand which patients with oligometastatic #pancreaticcancer would benefit from surgery
🤔Should we be considering adjunctive Tx, such as vaccines, that might⬆️long-term control❓
February 8, 2025 at 8:28 PM
@hopkinspress.bsky.social
#GIOnc
✅@NeehaZaidi presented a slightly different view that we need studies to understand which patients with oligometastatic #pancreaticcancer would benefit from surgery
🤔Should we be considering adjunctive Tx, such as vaccines, that might⬆️long-term control❓
#GIOnc
✅@NeehaZaidi presented a slightly different view that we need studies to understand which patients with oligometastatic #pancreaticcancer would benefit from surgery
🤔Should we be considering adjunctive Tx, such as vaccines, that might⬆️long-term control❓
@hopkinspress.bsky.social
#GIOnc
👉Some patients with limited metastatic #colorectalcancer can be cured
🤔Can we find which patients with metastatic #pancreaticcancer might also benefit from surgery❓
Dr. Rick Burkhart🗣️the support for surgery for limited, oligometastatic pancreatic cancer
#GIOnc
👉Some patients with limited metastatic #colorectalcancer can be cured
🤔Can we find which patients with metastatic #pancreaticcancer might also benefit from surgery❓
Dr. Rick Burkhart🗣️the support for surgery for limited, oligometastatic pancreatic cancer
February 8, 2025 at 8:19 PM
@hopkinspress.bsky.social
#GIOnc
👉Some patients with limited metastatic #colorectalcancer can be cured
🤔Can we find which patients with metastatic #pancreaticcancer might also benefit from surgery❓
Dr. Rick Burkhart🗣️the support for surgery for limited, oligometastatic pancreatic cancer
#GIOnc
👉Some patients with limited metastatic #colorectalcancer can be cured
🤔Can we find which patients with metastatic #pancreaticcancer might also benefit from surgery❓
Dr. Rick Burkhart🗣️the support for surgery for limited, oligometastatic pancreatic cancer
@hopkinspress.bsky.social
#GIOnc
🤔We🗣️the use of radiation☢️for localized pancreatic cancer
➡️Randomized trials (with some flaws) have not supported☢️
BUT there is some evidence that ablative☢️may actually⬆️mOS
Dr. Amol Narang reviewed this data - giving us a lot of food for thought💭
#GIOnc
🤔We🗣️the use of radiation☢️for localized pancreatic cancer
➡️Randomized trials (with some flaws) have not supported☢️
BUT there is some evidence that ablative☢️may actually⬆️mOS
Dr. Amol Narang reviewed this data - giving us a lot of food for thought💭
February 8, 2025 at 7:56 PM
@hopkinspress.bsky.social
#GIOnc
🤔We🗣️the use of radiation☢️for localized pancreatic cancer
➡️Randomized trials (with some flaws) have not supported☢️
BUT there is some evidence that ablative☢️may actually⬆️mOS
Dr. Amol Narang reviewed this data - giving us a lot of food for thought💭
#GIOnc
🤔We🗣️the use of radiation☢️for localized pancreatic cancer
➡️Randomized trials (with some flaws) have not supported☢️
BUT there is some evidence that ablative☢️may actually⬆️mOS
Dr. Amol Narang reviewed this data - giving us a lot of food for thought💭
@hopkinspress.bsky.social
#GIOnc
👉You have listen to @EileenMOReilly 🗣️ #PancreaticCancer
➡️Not only does she present a truly comprehensive review of treatment options
🙏But, she has a real knack for raising our hope for improvement for this devastating disease‼️
@PanCAN
#WageHope
#GIOnc
👉You have listen to @EileenMOReilly 🗣️ #PancreaticCancer
➡️Not only does she present a truly comprehensive review of treatment options
🙏But, she has a real knack for raising our hope for improvement for this devastating disease‼️
@PanCAN
#WageHope
February 8, 2025 at 7:28 PM
@hopkinspress.bsky.social
#GIOnc
👉You have listen to @EileenMOReilly 🗣️ #PancreaticCancer
➡️Not only does she present a truly comprehensive review of treatment options
🙏But, she has a real knack for raising our hope for improvement for this devastating disease‼️
@PanCAN
#WageHope
#GIOnc
👉You have listen to @EileenMOReilly 🗣️ #PancreaticCancer
➡️Not only does she present a truly comprehensive review of treatment options
🙏But, she has a real knack for raising our hope for improvement for this devastating disease‼️
@PanCAN
#WageHope
@hopkinspress.bsky.social
#GIOnc
😀I have been eagerly awaiting this Keynote👩🏫session on targeting🎯KRAS and the KRAS⛔️ by Dr. Nilo Azad
➡️KRAS inhibition looks so promising for out #GICancer patients particularly #pancreaticcancer and #colorectalcancer
#GIOnc
😀I have been eagerly awaiting this Keynote👩🏫session on targeting🎯KRAS and the KRAS⛔️ by Dr. Nilo Azad
➡️KRAS inhibition looks so promising for out #GICancer patients particularly #pancreaticcancer and #colorectalcancer
February 8, 2025 at 6:45 PM
@hopkinspress.bsky.social
#GIOnc
😀I have been eagerly awaiting this Keynote👩🏫session on targeting🎯KRAS and the KRAS⛔️ by Dr. Nilo Azad
➡️KRAS inhibition looks so promising for out #GICancer patients particularly #pancreaticcancer and #colorectalcancer
#GIOnc
😀I have been eagerly awaiting this Keynote👩🏫session on targeting🎯KRAS and the KRAS⛔️ by Dr. Nilo Azad
➡️KRAS inhibition looks so promising for out #GICancer patients particularly #pancreaticcancer and #colorectalcancer
@hopkinspress.bsky.social
#GIOnc
✅Keeping the patient's very personal experience front and center, Cindy Papesh Shephard, our wound/ostomy nurse educates all of us - especially the docs on how to manage and live with an ostomy
#GIOnc
✅Keeping the patient's very personal experience front and center, Cindy Papesh Shephard, our wound/ostomy nurse educates all of us - especially the docs on how to manage and live with an ostomy
February 8, 2025 at 5:23 PM
@hopkinspress.bsky.social
#GIOnc
✅Keeping the patient's very personal experience front and center, Cindy Papesh Shephard, our wound/ostomy nurse educates all of us - especially the docs on how to manage and live with an ostomy
#GIOnc
✅Keeping the patient's very personal experience front and center, Cindy Papesh Shephard, our wound/ostomy nurse educates all of us - especially the docs on how to manage and live with an ostomy
@hopkinspress.bsky.social
#GIOnc
@skopetz is back on stage to🗣️targeted therapies🎯💊for #colorectalcancer
➡️His group brought encorafenib + cetuximab to the forefront for BRAFV600E-mutated CRC🙏
➡️Overcoming resistance to KRAS⛔️with chemo or IO
➡️Epigenetics
➡️Other2⃣-ary🧬mutations
#GIOnc
@skopetz is back on stage to🗣️targeted therapies🎯💊for #colorectalcancer
➡️His group brought encorafenib + cetuximab to the forefront for BRAFV600E-mutated CRC🙏
➡️Overcoming resistance to KRAS⛔️with chemo or IO
➡️Epigenetics
➡️Other2⃣-ary🧬mutations
February 8, 2025 at 5:16 PM
@hopkinspress.bsky.social
#GIOnc
@skopetz is back on stage to🗣️targeted therapies🎯💊for #colorectalcancer
➡️His group brought encorafenib + cetuximab to the forefront for BRAFV600E-mutated CRC🙏
➡️Overcoming resistance to KRAS⛔️with chemo or IO
➡️Epigenetics
➡️Other2⃣-ary🧬mutations
#GIOnc
@skopetz is back on stage to🗣️targeted therapies🎯💊for #colorectalcancer
➡️His group brought encorafenib + cetuximab to the forefront for BRAFV600E-mutated CRC🙏
➡️Overcoming resistance to KRAS⛔️with chemo or IO
➡️Epigenetics
➡️Other2⃣-ary🧬mutations
@hopkinspress.bsky.social
#GIOnc
🤔How are you usuing ctDNA testing after resection of a #colorectalcancer ❓
✅Dr. Valerie Lee presented the current data, and the many persistent questions in this space
#GIOnc
🤔How are you usuing ctDNA testing after resection of a #colorectalcancer ❓
✅Dr. Valerie Lee presented the current data, and the many persistent questions in this space
February 8, 2025 at 5:02 PM
@hopkinspress.bsky.social
#GIOnc
🤔How are you usuing ctDNA testing after resection of a #colorectalcancer ❓
✅Dr. Valerie Lee presented the current data, and the many persistent questions in this space
#GIOnc
🤔How are you usuing ctDNA testing after resection of a #colorectalcancer ❓
✅Dr. Valerie Lee presented the current data, and the many persistent questions in this space
@hopkinspress.bsky.social
#GIOnc
✅Whereas, Dr. Ada Graham makes the case for the importance and essential nature of surgery🔪(and some of the challenges with radiation therapy☢️) for rectal cancer
#GIOnc
✅Whereas, Dr. Ada Graham makes the case for the importance and essential nature of surgery🔪(and some of the challenges with radiation therapy☢️) for rectal cancer
February 8, 2025 at 4:59 PM
@hopkinspress.bsky.social
#GIOnc
✅Whereas, Dr. Ada Graham makes the case for the importance and essential nature of surgery🔪(and some of the challenges with radiation therapy☢️) for rectal cancer
#GIOnc
✅Whereas, Dr. Ada Graham makes the case for the importance and essential nature of surgery🔪(and some of the challenges with radiation therapy☢️) for rectal cancer
@hopkinspress.bsky.social
#GIOnc
✅Dr. Rachit Kumar, from Radiation Oncology makes a case for chemoradiation, followed by watchful-waiting for rectal cancer with a complete clinical response
#GIOnc
✅Dr. Rachit Kumar, from Radiation Oncology makes a case for chemoradiation, followed by watchful-waiting for rectal cancer with a complete clinical response
February 8, 2025 at 4:46 PM
@hopkinspress.bsky.social
#GIOnc
✅Dr. Rachit Kumar, from Radiation Oncology makes a case for chemoradiation, followed by watchful-waiting for rectal cancer with a complete clinical response
#GIOnc
✅Dr. Rachit Kumar, from Radiation Oncology makes a case for chemoradiation, followed by watchful-waiting for rectal cancer with a complete clinical response
@hopkinspress.bsky.social
#GIOnc
#RectalCancer mgmt is IMHO the most complicated part of CRC Tx
😟It's harder to decide what we DON'T need to include (i.e. no🔪 or no☢️)
Dr. Valerie Lee from @HopkinsMedicine set up the🗣️and debate on how to manage a patient with a localized rectal cancer
#GIOnc
#RectalCancer mgmt is IMHO the most complicated part of CRC Tx
😟It's harder to decide what we DON'T need to include (i.e. no🔪 or no☢️)
Dr. Valerie Lee from @HopkinsMedicine set up the🗣️and debate on how to manage a patient with a localized rectal cancer
February 8, 2025 at 4:30 PM
@hopkinspress.bsky.social
#GIOnc
#RectalCancer mgmt is IMHO the most complicated part of CRC Tx
😟It's harder to decide what we DON'T need to include (i.e. no🔪 or no☢️)
Dr. Valerie Lee from @HopkinsMedicine set up the🗣️and debate on how to manage a patient with a localized rectal cancer
#GIOnc
#RectalCancer mgmt is IMHO the most complicated part of CRC Tx
😟It's harder to decide what we DON'T need to include (i.e. no🔪 or no☢️)
Dr. Valerie Lee from @HopkinsMedicine set up the🗣️and debate on how to manage a patient with a localized rectal cancer
@hopkinspress.bsky.social
#GIOnc
✅@skopetz.bsky.social guides us through what has become a very complicated field - the management of metastatic, newly diagnosed #colorectalcancer
➡️Triplet vs. doublet chemotherapy
➡️Right vs. Left-sided cancers
➡️Incorporating biomarkers
#GIOnc
✅@skopetz.bsky.social guides us through what has become a very complicated field - the management of metastatic, newly diagnosed #colorectalcancer
➡️Triplet vs. doublet chemotherapy
➡️Right vs. Left-sided cancers
➡️Incorporating biomarkers
February 8, 2025 at 4:13 PM
@hopkinspress.bsky.social
#GIOnc
✅@skopetz.bsky.social guides us through what has become a very complicated field - the management of metastatic, newly diagnosed #colorectalcancer
➡️Triplet vs. doublet chemotherapy
➡️Right vs. Left-sided cancers
➡️Incorporating biomarkers
#GIOnc
✅@skopetz.bsky.social guides us through what has become a very complicated field - the management of metastatic, newly diagnosed #colorectalcancer
➡️Triplet vs. doublet chemotherapy
➡️Right vs. Left-sided cancers
➡️Incorporating biomarkers
@hopkinspress.bsky.social
#GIOnc
🧑⚕️We have to consider symptom management in our patients with upper GI cancers
✅Dr. Saowanee Ngamruengphong from Johns Hopkins is a gastroenterologist that provided her advice on the management of severe gastroesophageal reflux after an esophagectomy
#GIOnc
🧑⚕️We have to consider symptom management in our patients with upper GI cancers
✅Dr. Saowanee Ngamruengphong from Johns Hopkins is a gastroenterologist that provided her advice on the management of severe gastroesophageal reflux after an esophagectomy
February 8, 2025 at 3:17 PM
@hopkinspress.bsky.social
#GIOnc
🧑⚕️We have to consider symptom management in our patients with upper GI cancers
✅Dr. Saowanee Ngamruengphong from Johns Hopkins is a gastroenterologist that provided her advice on the management of severe gastroesophageal reflux after an esophagectomy
#GIOnc
🧑⚕️We have to consider symptom management in our patients with upper GI cancers
✅Dr. Saowanee Ngamruengphong from Johns Hopkins is a gastroenterologist that provided her advice on the management of severe gastroesophageal reflux after an esophagectomy
@hopkinspress.bsky.social
#GIOnc
🗒️Treatment options for advanced upper GI cancers have expanded quite a bit in the last ~10 years
✅Dr. Manish Shah highlighted🔦the many options, in particular targeted therapy🎯💊options in the treatment of advanced gastric/GEJ/esophageal cancers
#GIOnc
🗒️Treatment options for advanced upper GI cancers have expanded quite a bit in the last ~10 years
✅Dr. Manish Shah highlighted🔦the many options, in particular targeted therapy🎯💊options in the treatment of advanced gastric/GEJ/esophageal cancers
February 8, 2025 at 3:07 PM
@hopkinspress.bsky.social
#GIOnc
🗒️Treatment options for advanced upper GI cancers have expanded quite a bit in the last ~10 years
✅Dr. Manish Shah highlighted🔦the many options, in particular targeted therapy🎯💊options in the treatment of advanced gastric/GEJ/esophageal cancers
#GIOnc
🗒️Treatment options for advanced upper GI cancers have expanded quite a bit in the last ~10 years
✅Dr. Manish Shah highlighted🔦the many options, in particular targeted therapy🎯💊options in the treatment of advanced gastric/GEJ/esophageal cancers
@hopkinspress.bsky.social
#GIOnc
✅Dr. Jeremy Davis from @ummedschool.bsky.social gave a very⏲️timely🗣️, fresh off the #GI25 👩🏫of the DRAGON-01 trial
🤔Should we consider surgery🔪(gastrectomy + cytoreduction +/- HIPEC) for a patient with metastatic gastric cancer with peritoneal carcinomatosis
#GIOnc
✅Dr. Jeremy Davis from @ummedschool.bsky.social gave a very⏲️timely🗣️, fresh off the #GI25 👩🏫of the DRAGON-01 trial
🤔Should we consider surgery🔪(gastrectomy + cytoreduction +/- HIPEC) for a patient with metastatic gastric cancer with peritoneal carcinomatosis
February 8, 2025 at 2:47 PM
@hopkinspress.bsky.social
#GIOnc
✅Dr. Jeremy Davis from @ummedschool.bsky.social gave a very⏲️timely🗣️, fresh off the #GI25 👩🏫of the DRAGON-01 trial
🤔Should we consider surgery🔪(gastrectomy + cytoreduction +/- HIPEC) for a patient with metastatic gastric cancer with peritoneal carcinomatosis
#GIOnc
✅Dr. Jeremy Davis from @ummedschool.bsky.social gave a very⏲️timely🗣️, fresh off the #GI25 👩🏫of the DRAGON-01 trial
🤔Should we consider surgery🔪(gastrectomy + cytoreduction +/- HIPEC) for a patient with metastatic gastric cancer with peritoneal carcinomatosis
@hopkinspress.bsky.social
#GIOnc
🤔Or, do you prefer to incoroporate radiation☢️
➡️Dr. Adi Halthore makes a case for chemoradiation (i.e. the CROSS regimen)
#GIOnc
🤔Or, do you prefer to incoroporate radiation☢️
➡️Dr. Adi Halthore makes a case for chemoradiation (i.e. the CROSS regimen)
February 8, 2025 at 2:34 PM
@hopkinspress.bsky.social
#GIOnc
🤔Or, do you prefer to incoroporate radiation☢️
➡️Dr. Adi Halthore makes a case for chemoradiation (i.e. the CROSS regimen)
#GIOnc
🤔Or, do you prefer to incoroporate radiation☢️
➡️Dr. Adi Halthore makes a case for chemoradiation (i.e. the CROSS regimen)
@hopkinspress.bsky.social
#GIOnc
🤔What are your thoughts on the management of a localized esophageal/gastroesophageal cancer❓
➡️Do you prefer perioperative chemotherapy alone ❓
✅Dr. Bever makes a case for the ESOPEC data supporting the use of perioperative FLOT
#GIOnc
🤔What are your thoughts on the management of a localized esophageal/gastroesophageal cancer❓
➡️Do you prefer perioperative chemotherapy alone ❓
✅Dr. Bever makes a case for the ESOPEC data supporting the use of perioperative FLOT
February 8, 2025 at 2:22 PM
@hopkinspress.bsky.social
#GIOnc
🤔What are your thoughts on the management of a localized esophageal/gastroesophageal cancer❓
➡️Do you prefer perioperative chemotherapy alone ❓
✅Dr. Bever makes a case for the ESOPEC data supporting the use of perioperative FLOT
#GIOnc
🤔What are your thoughts on the management of a localized esophageal/gastroesophageal cancer❓
➡️Do you prefer perioperative chemotherapy alone ❓
✅Dr. Bever makes a case for the ESOPEC data supporting the use of perioperative FLOT
@hopkinspress.bsky.social
#GIOnc
🌇Starting the day out with Upper GI Cancers
Dr. Manish Shah is walking🚶us through all the updates, and highlighting the progress that has been made in the fight against gastric/gastroesophageal/esophageal cancers
#GIOnc
🌇Starting the day out with Upper GI Cancers
Dr. Manish Shah is walking🚶us through all the updates, and highlighting the progress that has been made in the fight against gastric/gastroesophageal/esophageal cancers
February 8, 2025 at 2:05 PM
@hopkinspress.bsky.social
#GIOnc
🌇Starting the day out with Upper GI Cancers
Dr. Manish Shah is walking🚶us through all the updates, and highlighting the progress that has been made in the fight against gastric/gastroesophageal/esophageal cancers
#GIOnc
🌇Starting the day out with Upper GI Cancers
Dr. Manish Shah is walking🚶us through all the updates, and highlighting the progress that has been made in the fight against gastric/gastroesophageal/esophageal cancers
@hopkinspress.bsky.social
#GIOnc
📢Launching Day 2⃣‼️
😀I am confident that today's sessions will be as GREAT as yesterday's sessions
So - join us NOW for this 3rd Annual Johns Hopkins Updates in Gastrointestinal Cancers Conference
#GIOnc
📢Launching Day 2⃣‼️
😀I am confident that today's sessions will be as GREAT as yesterday's sessions
So - join us NOW for this 3rd Annual Johns Hopkins Updates in Gastrointestinal Cancers Conference
February 8, 2025 at 2:03 PM
@hopkinspress.bsky.social
#GIOnc
📢Launching Day 2⃣‼️
😀I am confident that today's sessions will be as GREAT as yesterday's sessions
So - join us NOW for this 3rd Annual Johns Hopkins Updates in Gastrointestinal Cancers Conference
#GIOnc
📢Launching Day 2⃣‼️
😀I am confident that today's sessions will be as GREAT as yesterday's sessions
So - join us NOW for this 3rd Annual Johns Hopkins Updates in Gastrointestinal Cancers Conference
@hopkinspress.bsky.social
#GI Onc
➡️In a recurrent theme for today (and possibly most relevant for NETs) for patients with low grade NETs with limited liver metastatic Dz, should we pursue "local" Tx❓
👉Surgery
👉Or liver-directed Tx
@KLafaro and Dr. Kelvin Hong discussed these2⃣options
#GI Onc
➡️In a recurrent theme for today (and possibly most relevant for NETs) for patients with low grade NETs with limited liver metastatic Dz, should we pursue "local" Tx❓
👉Surgery
👉Or liver-directed Tx
@KLafaro and Dr. Kelvin Hong discussed these2⃣options
February 7, 2025 at 9:41 PM
@hopkinspress.bsky.social
#GI Onc
➡️In a recurrent theme for today (and possibly most relevant for NETs) for patients with low grade NETs with limited liver metastatic Dz, should we pursue "local" Tx❓
👉Surgery
👉Or liver-directed Tx
@KLafaro and Dr. Kelvin Hong discussed these2⃣options
#GI Onc
➡️In a recurrent theme for today (and possibly most relevant for NETs) for patients with low grade NETs with limited liver metastatic Dz, should we pursue "local" Tx❓
👉Surgery
👉Or liver-directed Tx
@KLafaro and Dr. Kelvin Hong discussed these2⃣options
@hopkinspress.bsky.social
#GIOnc
⏲️It is time for Dr. Aman Chauhan from the University of Miami Sylvester Cancer Center to talk to us about peptide radiotherapy #PRRT
#GIOnc
⏲️It is time for Dr. Aman Chauhan from the University of Miami Sylvester Cancer Center to talk to us about peptide radiotherapy #PRRT
February 7, 2025 at 9:07 PM
@hopkinspress.bsky.social
#GIOnc
⏲️It is time for Dr. Aman Chauhan from the University of Miami Sylvester Cancer Center to talk to us about peptide radiotherapy #PRRT
#GIOnc
⏲️It is time for Dr. Aman Chauhan from the University of Miami Sylvester Cancer Center to talk to us about peptide radiotherapy #PRRT
@hopkinspress.bsky.social
#GIOnc
👉Ana DeJesus Acosta helps us understand how best to manage patients with high grade neuroendocrine carcinomas
✅Standard of care is still cisplatin + etoposide and cape-tem
🙏Need novel therapeutic options for this disease
#GIOnc
👉Ana DeJesus Acosta helps us understand how best to manage patients with high grade neuroendocrine carcinomas
✅Standard of care is still cisplatin + etoposide and cape-tem
🙏Need novel therapeutic options for this disease
February 7, 2025 at 8:52 PM
@hopkinspress.bsky.social
#GIOnc
👉Ana DeJesus Acosta helps us understand how best to manage patients with high grade neuroendocrine carcinomas
✅Standard of care is still cisplatin + etoposide and cape-tem
🙏Need novel therapeutic options for this disease
#GIOnc
👉Ana DeJesus Acosta helps us understand how best to manage patients with high grade neuroendocrine carcinomas
✅Standard of care is still cisplatin + etoposide and cape-tem
🙏Need novel therapeutic options for this disease
@hopkinspress.bsky.social
#GIOnc
🚶♀️On to #neuroendocrine tumors starting with Jennifer Chan from @danafarber.bsky.social who gave us a super comprehensive review on systemic therapy for this disease
#GIOnc
🚶♀️On to #neuroendocrine tumors starting with Jennifer Chan from @danafarber.bsky.social who gave us a super comprehensive review on systemic therapy for this disease
February 7, 2025 at 8:19 PM
@hopkinspress.bsky.social
#GIOnc
🚶♀️On to #neuroendocrine tumors starting with Jennifer Chan from @danafarber.bsky.social who gave us a super comprehensive review on systemic therapy for this disease
#GIOnc
🚶♀️On to #neuroendocrine tumors starting with Jennifer Chan from @danafarber.bsky.social who gave us a super comprehensive review on systemic therapy for this disease